Dissecting human, ferret, and murine antibody and B cell responses to generate a broadly protective synthetic influenza virus hemagglutinin
Hyunsuh Kim(St. Jude Children's Research Hospital), Richard J. Webby(St. Jude Children's Research Hospital), Rafi Ahmed(Emory University), Jennifer DeBeauchamp(St. Jude Children's Research Hospital), Evelyn Stigger(St. Jude Children's Research Hospital), Ali H. Ellebedy(Washington University in St. Louis), John P. DeVincenzo(Enanta Pharmaceuticals (United States)), Rabeh El‐Shesheny(National Research Centre), Jeri Carol Crumpton(St. Jude Children's Research Hospital), Miguela A. Caniza(St. Jude Children's Research Hospital), Adam Rubrum(St. Jude Children's Research Hospital), Christina Kackos(St. Jude Children's Research Hospital), Paul G. Thomas(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851